{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:46:13Z","timestamp":1783773973626,"version":"3.55.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/or.2015.4232","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T04:25:58Z","timestamp":1440649558000},"page":"2715-2721","source":"Crossref","is-referenced-by-count":40,"title":["Interferon-\u03b1\/\u03b2 enhances temozolomide activity against MGMT-positive glioma stem-like cells"],"prefix":"10.3892","volume":"34","author":[{"given":"DONG","family":"SHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENG-CHENG","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHI-KUN","family":"QIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KE","family":"SAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QUN-YING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YIN-SHENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FU-RONG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIE","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAWRENCE","family":"PANASCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONG-PING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"key20180107212153_b1-or-34-05-2715","unstructured":"CBTRUSCBTRUS Statistical report: Primary brain and central nervoussystem tumors diagnosed in the United States in 2004\u20132007Source: Central Brain Tumor Registry of the United StatesCBTRUSHindsdale, IL, USA2011www.cbtrus.org"},{"key":"key20180107212153_b2-or-34-05-2715","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107212153_b3-or-34-05-2715","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180107212153_b4-or-34-05-2715","first-page":"4845","article-title":"Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT","volume":"29","author":"Fukushima","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107212153_b5-or-34-05-2715","first-page":"3759","article-title":"Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis","volume":"29","author":"Sharma","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107212153_b6-or-34-05-2715","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1158\/1078-0432.CCR-05-1830","article-title":"In vitro drug response and molecular markers associated with drug resistance in malignant gliomas","volume":"12","author":"Fruehauf","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107212153_b7-or-34-05-2715","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1471-4159.2005.03583.x","article-title":"O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells","volume":"96","author":"Hermisson","year":"2006","journal-title":"J Neurochem"},{"key":"key20180107212153_b8-or-34-05-2715","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180107212153_b9-or-34-05-2715","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107212153_b10-or-34-05-2715","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/glia.10094","article-title":"Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro","volume":"39","author":"Ignatova","year":"2002","journal-title":"Glia"},{"key":"key20180107212153_b11-or-34-05-2715","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"key20180107212153_b12-or-34-05-2715","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1073\/pnas.0307618100","article-title":"Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line","volume":"101","author":"Kondo","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212153_b13-or-34-05-2715","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","article-title":"Chemotherapy resistance of glioblastoma stem cells","volume":"13","author":"Eramo","year":"2006","journal-title":"Cell Death Differ"},{"key":"key20180107212153_b14-or-34-05-2715","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/glia.20414","article-title":"Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype","volume":"54","author":"Salmaggi","year":"2006","journal-title":"Glia"},{"key":"key20180107212153_b15-or-34-05-2715","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","article-title":"Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities","volume":"6","author":"Jonasch","year":"2001","journal-title":"Oncologist"},{"key":"key20180107212153_b16-or-34-05-2715","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jgm.1160","article-title":"A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: Novel findings from gene expression profiling and autopsy","volume":"10","author":"Wakabayashi","year":"2008","journal-title":"J Gene Med"},{"key":"key20180107212153_b17-or-34-05-2715","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bjc.6605189","article-title":"Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multi-forme","volume":"101","author":"Groves","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180107212153_b18-or-34-05-2715","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pbc.21987","article-title":"Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma","volume":"53","author":"Ohno","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"key20180107212153_b19-or-34-05-2715","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/cncr.26659","article-title":"A phase 2 study of pegylated interferon \u03b1-2b (PEG-Intron\u00ae) in children with diffuse intrinsic pontine glioma","volume":"118","author":"Warren","year":"2012","journal-title":"Cancer"},{"key":"key20180107212153_b20-or-34-05-2715","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1158\/0008-5472.CAN-05-0036","article-title":"IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide","volume":"65","author":"Natsume","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107212153_b21-or-34-05-2715","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00280-007-0520-x","article-title":"A combination of IFN-beta and temozolomide in human glioma xenograft models: Implication of p53-mediated MGMT downregulation","volume":"61","author":"Natsume","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107212153_b22-or-34-05-2715","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1158\/0008-5472.CAN-06-3820","article-title":"Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase","volume":"67","author":"Lavon","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107212153_b23-or-34-05-2715","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"Liu","year":"2006","journal-title":"Mol Cancer"},{"key":"key20180107212153_b24-or-34-05-2715","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5732\/cjc.012.10236","article-title":"Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells","volume":"33","author":"Qiu","year":"2014","journal-title":"Chin J Cancer"},{"key":"key20180107212153_b25-or-34-05-2715","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.dnarep.2007.03.011","article-title":"DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy","volume":"6","author":"Tubbs","year":"2007","journal-title":"DNA Repair"},{"key":"key20180107212153_b26-or-34-05-2715","first-page":"104","article-title":"Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients","volume":"26","author":"Chen","year":"1999","journal-title":"Can J Neurol Sci"},{"key":"key20180107212153_b27-or-34-05-2715","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1158\/1078-0432.CCR-04-0392","article-title":"CpG island hyper-methylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas","volume":"10","author":"Paz","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107212153_b28-or-34-05-2715","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","article-title":"Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity","volume":"26","author":"Hegi","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107212153_b29-or-34-05-2715","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2006.05.021","article-title":"Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblas-toma: Results of RTOG 9710","volume":"66","author":"Colman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107212153_b30-or-34-05-2715","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.25637","article-title":"Benefits of interferon-\u03b2 and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study","volume":"117","author":"Motomura","year":"2011","journal-title":"Cancer"},{"key":"key20180107212153_b31-or-34-05-2715","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.20040196","article-title":"Degradation of promoter-bound p65\/RelA is essential for the prompt termination of the nuclear factor kappaB response","volume":"200","author":"Saccani","year":"2004","journal-title":"J Exp Med"},{"key":"key20180107212153_b32-or-34-05-2715","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1158\/1535-7163.MCT-07-2424","article-title":"Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis","volume":"7","author":"Sethi","year":"2008","journal-title":"Mol Cancer Ther"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4232\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:22:10Z","timestamp":1515342130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,8,27]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/or.2015.4232"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4232","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}